Annual Accounts Payable:
$7.33M-$4.11M(-35.90%)Summary
- As of today, AVDL annual accounts payable is $7.33 million, with the most recent change of -$4.11 million (-35.90%) on December 31, 2024.
- During the last 3 years, AVDL annual accounts payable has fallen by -$351.00 thousand (-4.57%).
- AVDL annual accounts payable is now -36.26% below its all-time high of $11.50 million, reached on December 31, 2005.
Performance
AVDL Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Accounts Payable:
$12.58M+$2.47M(+24.39%)Summary
- As of today, AVDL quarterly accounts payable is $12.58 million, with the most recent change of +$2.47 million (+24.39%) on September 30, 2025.
- Over the past year, AVDL quarterly accounts payable has increased by +$4.66 million (+58.91%).
- AVDL quarterly accounts payable is now -33.65% below its all-time high of $18.96 million, reached on March 31, 2024.
Performance
AVDL Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
AVDL Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | -35.9% | +58.9% |
| 3Y3 Years | -4.6% | +407.5% |
| 5Y5 Years | +20.1% | +373.0% |
AVDL Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | -35.9% | at low | -33.6% | +407.5% |
| 5Y | 5-Year | -35.9% | +149.8% | -33.6% | +407.5% |
| All-Time | All-Time | -36.3% | +508.1% | -33.6% | +1082.4% |
AVDL Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2025 | - | $12.58M(+24.4%) |
| Jun 2025 | - | $10.11M(+10.9%) |
| Mar 2025 | - | $9.12M(+24.4%) |
| Dec 2024 | $7.33M(-35.9%) | $7.33M(-7.4%) |
| Sep 2024 | - | $7.92M(-19.2%) |
| Jun 2024 | - | $9.79M(-48.3%) |
| Mar 2024 | - | $18.96M(+65.8%) |
| Dec 2023 | $11.43M(+44.9%) | $11.43M(-13.8%) |
| Sep 2023 | - | $13.26M(+12.5%) |
| Jun 2023 | - | $11.79M(+17.6%) |
| Mar 2023 | - | $10.02M(+27.0%) |
| Dec 2022 | $7.89M(+2.7%) | $7.89M(+218.3%) |
| Sep 2022 | - | $2.48M(-66.1%) |
| Jun 2022 | - | $7.32M(+21.0%) |
| Mar 2022 | - | $6.05M(-21.2%) |
| Dec 2021 | $7.68M(+161.7%) | $7.68M(+11.7%) |
| Sep 2021 | - | $6.87M(+34.4%) |
| Jun 2021 | - | $5.12M(+81.2%) |
| Mar 2021 | - | $2.82M(-3.7%) |
| Dec 2020 | $2.93M(-51.9%) | $2.93M(+10.3%) |
| Sep 2020 | - | $2.66M(-45.5%) |
| Jun 2020 | - | $4.88M(-28.1%) |
| Mar 2020 | - | $6.79M(+11.3%) |
| Dec 2019 | $6.10M(+74.1%) | $6.10M(+72.4%) |
| Sep 2019 | - | $3.54M(-26.3%) |
| Jun 2019 | - | $4.80M(+15.6%) |
| Mar 2019 | - | $4.15M(+18.5%) |
| Dec 2018 | $3.50M(-53.1%) | $3.50M(-69.3%) |
| Sep 2018 | - | $11.40M(+2.1%) |
| Jun 2018 | - | $11.17M(-29.8%) |
| Mar 2018 | - | $15.91M(+112.7%) |
| Dec 2017 | $7.48M(+5.2%) | $7.48M(-12.7%) |
| Sep 2017 | - | $8.56M(-30.5%) |
| Jun 2017 | - | $12.32M(+54.7%) |
| Mar 2017 | - | $7.96M(+12.1%) |
| Dec 2016 | $7.11M(+40.7%) | $7.11M(-20.8%) |
| Sep 2016 | - | $8.97M(+27.3%) |
| Jun 2016 | - | $7.04M(-60.2%) |
| Mar 2016 | - | $17.67M(+67.3%) |
| Dec 2015 | $5.05M(-37.1%) | $10.56M(+16.9%) |
| Mar 2015 | - | $9.04M(+12.6%) |
| Dec 2014 | $8.02M | $8.02M(+14.5%) |
| Sep 2014 | - | $7.01M(+13.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2014 | - | $6.17M(-3.0%) |
| Mar 2014 | - | $6.36M(+24.7%) |
| Dec 2013 | $5.10M(+41.8%) | $5.10M(+23.9%) |
| Sep 2013 | - | $4.12M(+25.9%) |
| Jun 2013 | - | $3.27M(-4.6%) |
| Mar 2013 | - | $3.42M(-4.8%) |
| Dec 2012 | $3.60M(-8.3%) | $3.60M(-24.4%) |
| Jun 2012 | - | $4.76M(+1.8%) |
| Mar 2012 | - | $4.67M(+19.3%) |
| Dec 2011 | $3.92M(-20.7%) | $3.92M(+14.2%) |
| Sep 2011 | - | $3.43M(-13.8%) |
| Jun 2011 | - | $3.98M(-15.4%) |
| Mar 2011 | - | $4.71M(-4.8%) |
| Dec 2010 | $4.94M(-22.4%) | $4.94M(-4.2%) |
| Sep 2010 | - | $5.16M(-19.0%) |
| Dec 2009 | $6.37M(+10.5%) | $6.37M(+10.5%) |
| Dec 2008 | $5.76M(-32.8%) | $5.76M(-32.8%) |
| Dec 2007 | $8.57M(-11.7%) | $8.57M(-33.8%) |
| Sep 2007 | - | $12.93M(-1.1%) |
| Jun 2007 | - | $13.07M(+27.5%) |
| Mar 2007 | - | $10.25M(+5.7%) |
| Dec 2006 | $9.70M(-15.6%) | $9.70M(-15.6%) |
| Dec 2005 | $11.50M(+19.0%) | $11.50M(+3.9%) |
| Sep 2005 | - | $11.07M(-28.5%) |
| Jun 2005 | - | $15.49M(+98.3%) |
| Mar 2005 | - | $7.81M(-19.1%) |
| Dec 2004 | $9.66M(+119.7%) | $9.66M(+38.8%) |
| Sep 2004 | - | $6.96M(0.0%) |
| Jun 2004 | - | $6.96M(-0.8%) |
| Mar 2004 | - | $7.02M(+59.7%) |
| Dec 2003 | $4.40M(+232.6%) | $4.40M(+86.6%) |
| Sep 2003 | - | $2.36M(-1.3%) |
| Jun 2003 | - | $2.39M(+9.3%) |
| Mar 2003 | - | $2.18M(+65.2%) |
| Dec 2002 | $1.32M(+9.7%) | $1.32M(+24.2%) |
| Sep 2002 | - | $1.06M(-11.7%) |
| Dec 2001 | $1.21M(-21.8%) | $1.21M(-21.8%) |
| Dec 2000 | $1.54M(+1.4%) | $1.54M(+1.4%) |
| Dec 1999 | $1.52M(-41.5%) | $1.52M(-41.5%) |
| Dec 1998 | $2.60M(+3.9%) | $2.60M(-7.2%) |
| Mar 1998 | - | $2.80M(+12.0%) |
| Dec 1997 | $2.50M(-19.4%) | $2.50M(-19.4%) |
| Dec 1996 | $3.10M | $3.10M(+55.0%) |
| Mar 1996 | - | $2.00M |
FAQ
- What is Avadel Pharmaceuticals plc annual accounts payable?
- What is the all-time high annual accounts payable for Avadel Pharmaceuticals plc?
- What is Avadel Pharmaceuticals plc annual accounts payable year-on-year change?
- What is Avadel Pharmaceuticals plc quarterly accounts payable?
- What is the all-time high quarterly accounts payable for Avadel Pharmaceuticals plc?
- What is Avadel Pharmaceuticals plc quarterly accounts payable year-on-year change?
What is Avadel Pharmaceuticals plc annual accounts payable?
The current annual accounts payable of AVDL is $7.33M
What is the all-time high annual accounts payable for Avadel Pharmaceuticals plc?
Avadel Pharmaceuticals plc all-time high annual accounts payable is $11.50M
What is Avadel Pharmaceuticals plc annual accounts payable year-on-year change?
Over the past year, AVDL annual accounts payable has changed by -$4.11M (-35.90%)
What is Avadel Pharmaceuticals plc quarterly accounts payable?
The current quarterly accounts payable of AVDL is $12.58M
What is the all-time high quarterly accounts payable for Avadel Pharmaceuticals plc?
Avadel Pharmaceuticals plc all-time high quarterly accounts payable is $18.96M
What is Avadel Pharmaceuticals plc quarterly accounts payable year-on-year change?
Over the past year, AVDL quarterly accounts payable has changed by +$4.66M (+58.91%)